
Sign up to save your podcasts
Or


Vaccine advisers to the CDC had voted unanimously on Saturday in support of recommending the two-dose Moderna and three-dose Pfizer/BioNTech vaccines to children as young as 6 months.
The long-awaited development is both a triumph and a curiosity to many. The prospect of more protection for more people is, of course, good news. But consider the following:
See omnystudio.com/listener for privacy information.
By The John Rothmann ShowVaccine advisers to the CDC had voted unanimously on Saturday in support of recommending the two-dose Moderna and three-dose Pfizer/BioNTech vaccines to children as young as 6 months.
The long-awaited development is both a triumph and a curiosity to many. The prospect of more protection for more people is, of course, good news. But consider the following:
See omnystudio.com/listener for privacy information.